A plethora of ocular surface manifestations in a multidisciplinary ocular graft-versus-host disease unit

[1]  L. Drolsum,et al.  Ocular findings and ocular graft-versus-host disease after allogeneic stem cell transplantation without total body irradiation , 2018, Bone Marrow Transplantation.

[2]  K. Tsubota,et al.  TFOS DEWS II Definition and Classification Report. , 2017, The ocular surface.

[3]  D. Schaumberg,et al.  TFOS DEWS II Epidemiology Report. , 2017, The ocular surface.

[4]  J. Wolffsohn,et al.  TFOS DEWS II Diagnostic Methodology report. , 2017, The ocular surface.

[5]  Saleha Z. Munir,et al.  A Review of Ocular Graft-Versus-Host Disease. , 2017, Optometry and vision science : official publication of the American Academy of Optometry.

[6]  A. Movahedan,et al.  Superior Limbic Keratoconjunctivitis-like Inflammation in Patients with Chronic Graft-Versus-Host Disease. , 2016, The ocular surface.

[7]  E. Holler,et al.  Verification of the new grading scale for ocular chronic graft-versus-host disease developed by the German-Austrian-Swiss consensus conference on chronic GVHD , 2016, Annals of Hematology.

[8]  J. W. Lee,et al.  Incidence and risk factors for ocular GVHD after allogeneic hematopoietic stem cell transplantation , 2015, Bone Marrow Transplantation.

[9]  R. Dana,et al.  Onset of Ocular Graft-Versus-Host Disease Symptoms After Allogeneic Hematopoietic Stem Cell Transplantation , 2015, Cornea.

[10]  Paul J Martin,et al.  How we treat chronic graft-versus-host disease. , 2015, Blood.

[11]  J. Clayton,et al.  International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: Proposed Diagnostic Criteria for Chronic GVHD (Part I) , 2013, Scientific Reports.

[12]  R. Dana,et al.  Bilateral corneal ulceration in ocular graft-versus-host disease , 2013, Clinical ophthalmology.

[13]  N. Nassiri,et al.  Ocular Graft Versus Host Disease Following Allogeneic Stem Cell Transplantation: A Review of Current Knowledge and Recommendations , 2013, Journal of ophthalmic & vision research.

[14]  R. Dana,et al.  Ocular graft-versus-host disease: a review. , 2013, Survey of ophthalmology.

[15]  B. Kurland,et al.  Validation of measurement scales in ocular graft-versus-host disease. , 2012, Ophthalmology.

[16]  R. Dana,et al.  Dry eye disease: an immune-mediated ocular surface disorder. , 2012, Archives of ophthalmology.

[17]  M. Flowers,et al.  Visual Acuity and Anterior Segment Findings in Chronic Graft-Versus-Host Disease , 2011, Cornea.

[18]  B. Storer,et al.  Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria. , 2011, Blood.

[19]  B. Geramizadeh,et al.  Conjunctival Scrape Cytology Findings in Patients with Chronic Graft-Versus-Host Disease Following Allogeneic Bone Marrow Transplantation , 2010, Acta Cytologica.

[20]  Daniel Wolff,et al.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[21]  G. Vogelsang,et al.  Chronic graft versus host disease , 2004, British journal of haematology.

[22]  T. Braun,et al.  Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma , 2001, Bone Marrow Transplantation.

[23]  K. Tsubota,et al.  Dry eye after haematopoietic stem cell transplantation , 1999, The British journal of ophthalmology.

[24]  David Brink,et al.  : A Review of the , 2018 .

[25]  P. Chevallier,et al.  Late Complications and Quality of Life after Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[26]  R. Dana,et al.  An Immune-Mediated Ocular Surface Disorder , 2016 .

[27]  A. Bron,et al.  The Definition and Classification of Dry Eye Disease , 2015 .